La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
EMVision Medical Devices Résultats passés
Passé contrôle des critères 0/6
EMVision Medical Devices's earnings have been declining at an average annual rate of -9%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 40.8% per year.
Informations clés
-9.0%
Taux de croissance des bénéfices
1.1%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 5.8% |
| Taux de croissance des recettes | 40.8% |
| Rendement des fonds propres | -56.5% |
| Marge nette | -37.2% |
| Dernière mise à jour des bénéfices | 31 Dec 2023 |
Mises à jour récentes des performances passées
Recent updates
Is EMVision Medical Devices (ASX:EMV) A Risky Investment?
Nov 21
Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation
Apr 24EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment
Nov 09We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth
Jun 17We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jan 07We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jun 08Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation
Feb 22Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%
Dec 20
We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth
Nov 24Ventilation des recettes et des dépenses
Comment EMVision Medical Devices gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 23 | 9 | -3 | 8 | 3 |
| 30 Sep 23 | 8 | -4 | 8 | 3 |
| 30 Jun 23 | 7 | -4 | 8 | 2 |
| 31 Mar 23 | 6 | -4 | 8 | 2 |
| 31 Dec 22 | 6 | -5 | 8 | 2 |
| 30 Sep 22 | 5 | -5 | 8 | 2 |
| 30 Jun 22 | 4 | -6 | 8 | 2 |
| 31 Mar 22 | 4 | -7 | 8 | 2 |
| 31 Dec 21 | 3 | -7 | 8 | 2 |
| 30 Sep 21 | 3 | -8 | 8 | 2 |
| 30 Jun 21 | 2 | -8 | 7 | 3 |
| 31 Mar 21 | 2 | -7 | 6 | 3 |
| 31 Dec 20 | 2 | -5 | 4 | 3 |
| 30 Sep 20 | 2 | -4 | 3 | 3 |
| 30 Jun 20 | 2 | -3 | 2 | 3 |
| 31 Mar 20 | 2 | -3 | 2 | 3 |
| 31 Dec 19 | 2 | -3 | 2 | 3 |
| 30 Sep 19 | 2 | -3 | 2 | 2 |
| 30 Jun 19 | 1 | -3 | 2 | 2 |
| 31 Mar 19 | 1 | -3 | 2 | 2 |
| 31 Dec 18 | 1 | -2 | 2 | 2 |
| 30 Sep 18 | 1 | -2 | 1 | 1 |
| 30 Jun 18 | 0 | -1 | 0 | 1 |
| 30 Apr 18 | 1 | 0 | 0 | 1 |
Des revenus de qualité: EMV is currently unprofitable.
Augmentation de la marge bénéficiaire: EMV is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: EMV is unprofitable, and losses have increased over the past 5 years at a rate of 9% per year.
Accélération de la croissance: Unable to compare EMV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: EMV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Rendement des fonds propres
ROE élevé: EMV has a negative Return on Equity (-56.47%), as it is currently unprofitable.